Ayurcann Holdings Corp is set to enter a business combination with Arogo Capital Acquisition Corp and its subsidiaries. The estimated enterprise value of the combined entity stands at $210 million. Ayurcann has focused on operational efficiencies, market share growth, and quality product offerings in the cannabis sector. The management team attributes the company’s strong market position to its reputation for high-quality brands and continuous improvement in manufacturing and supply chain efficiencies. By leveraging a strong internal team and setting clear objectives, Ayurcann aims to drive growth and meet market demand effectively.

Cannabis Industry, Private Equity and Acquisitions,Canada, United States